Acquired ALK and RET Gene Fusions as Mechanisms of Resistance to Osimertinib in EGFR-Mutant Lung Cancers

Guardat en:
Dades bibliogràfiques
Publicat a:JCO Precis Oncol
Autors principals: Offin, Michael, Somwar, Romel, Rekhtman, Natasha, Benayed, Ryma, Chang, Jason C., Plodkowski, Andrew, Lui, Allan J.W., Eng, Juliana, Rosenblum, Marc, Li, Bob T., Riely, Gregory J., Rudin, Charles M., Kris, Mark G., Travis, William, Drilon, Alexander, Arcila, Maria E., Ladanyi, Marc, Yu, Helena A.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2018
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6447364/
https://ncbi.nlm.nih.gov/pubmed/30957057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.18.00126
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars